Abstract
Bone morphogenetic protein-2 (BMP-2) and other members of the TGF-β superfamily regulate the development, maintenance and regeneration of tissues and organs. Binding epitopes for these extracellular signaling proteins have been defined, but hot spots specifying binding affinity and specificity have so far not been identified. In this study, mutational and structural analyses show that epitopes of BMP-2 and the BRIA receptor form a new type of protein-protein interface. The main chain atoms of Leu 51 and Asp53 of BMP-2 represent a hot spot of binding to BRIA. The BMP-2 variant L51P was deficient in type I receptor binding only, whereas its overall structure and its binding to type II receptors and modulator proteins, such as noggin, were unchanged. Thus, the L51P substitution converts BMP-2 into a receptor-inactive inhibitor of noggin. These results are relevant for other proteins of the TGF-β superfamily and provide useful clues for structure-based drug design.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
11 April 2004
Replaces Supp Table 1 file, added note to full text after SI note and on Supp Info index page
Notes
*Note:The original Supplementary Table 1 contained symbol conversion errors and has been replaced with a new file.
References
Shi, Y. & Massague, J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685–700 (2003).
Heldin, C.H., Eriksson, U. & Ostman, A. New members of the platelet-derived growth factor family of mitogens. Arch. Biochem. Biophys. 398, 284–290 (2002).
Kirsch, T., Nickel, J. & Sebald, W. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. Embo J. 19, 3314–3324 (2000).
Harland, R.M. Developmental biology. A twist on embryonic signalling. Nature 410, 423–424 (2001).
Balemans, W. & Van Hul, W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250, 231–250 (2002).
Massague, J. & Chen, Y.G. Controlling TGF-β signaling. Genes Dev. 14, 627–644 (2000).
Garcia Abreu, J., Coffinier, C., Larrain, J., Oelgeschlager, M. & De Robertis, E.M. Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene 287, 39–47 (2002).
Groppe, J. et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420, 636–642 (2002).
Zimmerman, L.B., De Jesus-Escobar, J.M. & Harland, R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599–606 (1996).
Kirsch, T., Sebald, W. & Dreyer, M.K. Crystal structure of the BMP-2–BRIA ectodomain complex. Nat. Struct. Biol. 7, 492–496 (2000).
Hatta, T. et al. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4. Biopolymers 55, 399–406 (2000).
de Vos, A.M., Ultsch, M. & Kossiakoff, A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306–312 (1992).
Hage, T., Sebald, W. & Reinemer, P. Crystal structure of the interleukin-4/receptor α chain complex reveals a mosaic binding interface. Cell 97, 271–281 (1999).
Syed, R.S. et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511–516 (1998).
Boulanger, M.J., Chow, D.C., Brevnova, E.E. & Garcia, K.C. Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex. Science 300, 2101–2104 (2003).
Greenwald, J. et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605–617 (2003).
Hart, P.J. et al. Crystal structure of the human TβR2 ectodomain—TGF-β3 complex. Nat. Struct. Biol. 9, 203–208 (2002).
Thompson, T.B., Woodruff, T.K. & Jardetzky, T.S. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions. EMBO J. 22, 1555–1566 (2003).
McDonald, I.K. & Thornton, J.M. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238, 777–793 (1994).
Xu, D., Tsai, C.J. & Nussinov, R. Hydrogen bonds and salt bridges across protein-protein interfaces. Protein Eng. 10, 999–1012 (1997).
Chakrabarti, P. & Janin, J. Dissecting protein-protein recognition sites. Proteins 47, 334–343 (2002).
Bogan, A.A. & Thorn, K.S. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 280, 1–9 (1998).
Griffith, D.L., Keck, P.C., Sampath, T.K., Rueger, D.C. & Carlson, W.D. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. Proc. Natl. Acad. Sci. USA 93, 878–883 (1996).
Groppe, J. et al. Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein. J. Bone Joint. Surg. Am. 85, 52–58 (2003).
Huang, S.S., Zhou, M., Johnson, F.E., Shieh, H.S. & Huang, J.S. An active site of transforming growth factor-β1 for growth inhibition and stimulation. J. Biol. Chem. 274, 27754–27758 (1999).
Huang, S.S., Liu, Q., Johnson, F.E., Konish, Y. & Huang, J.S. Transforming growth factor β peptide antagonists and their conversion to partial agonists. J. Biol. Chem. 272, 27155–27159 (1997).
Ruppert, R., Hoffmann, E. & Sebald, W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237, 295–302 (1996).
Kirsch, T., Nickel, J. & Sebald, W. Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2. FEBS Lett. 468, 215–219 (2000).
Leslie, A.G.W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 ESF-EAMCB Newslett. Protein Crystallogr. 26 (1992).
Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
Evans, P.R. Data reduction. in Proceedings of CCP4 Study Weekend 114–122 (CLRC Daresbury Laboratory, Daresbury, UK, 1993).
Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240–255 (1997).
Winn, M.D., Isupov, M.N. & Murshudov, G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D 57, 122–133 (2001).
Brunger, A.T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472–475 (1992).
Kraulis, P.J. Molscript—a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24, 946–950 (1991).
Merritt, E.A. & Bacon, D.J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277, 505–524 (1997).
Nicholls, A., Sharp, K.A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281–296 (1991).
Esnouf, R.M. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr. D 55, 938–940 (1999).
Acknowledgements
We thank M. Gottermeier and C. Söder for excellent technical assistance; M. Klein for help during data acquisition; M. Buehner for helpful discussions and advice; and D. Heinz and W. Schubert (Gesellschaft für Biotechnologische Forschung, GbF Braunschweig) for providing access to their X-ray diffraction equipment. The authors also thank C. Schulze-Briese and T. Tomizaki from Swiss Light Source for assistance during data acquisition and would like to acknowledge their access to the synchrotron radiation beamline X06SA at the Swiss Light Source (SLS), Switzerland. This project was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB 487 TP B1 and B2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
*Note:The original Supplementary Table 1 contained symbol conversion errors and has been replaced with a new file. (PDF 125 kb)
Rights and permissions
About this article
Cite this article
Keller, S., Nickel, J., Zhang, JL. et al. Molecular recognition of BMP-2 and BMP receptor IA. Nat Struct Mol Biol 11, 481–488 (2004). https://doi.org/10.1038/nsmb756
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb756
This article is cited by
-
BMP2 as a promising anticancer approach: functions and molecular mechanisms
Investigational New Drugs (2022)
-
Structural Mapping of BMP Conformational Epitopes and Bioengineering Design of Osteogenic Peptides to Specifically Target the Epitope-Binding Sites
Cellular and Molecular Bioengineering (2022)
-
The versatility and paradox of BMP signaling in endothelial cell behaviors and blood vessel function
Cellular and Molecular Life Sciences (2022)
-
Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2
Journal of Biosciences (2019)
-
The BMP-2 mutant L51P: a BMP receptor IA binding-deficient inhibitor of noggin
Journal of Bone and Mineral Metabolism (2019)